Series C · Biotech
Basecamp Research raises $140M Series C led by S32
Basecamp Research raised $140 million in an oversubscribed Series C led by S32 in September.
Backers include the Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, the Rockefeller Foundation, Singular, Sovereign AI and True Ventures.
The financing will fund a new generation of EDEN biological models, advance the company’s therapeutic pipeline and expand pharmaceutical partnerships. Its initial therapeutic focus is in vivo cell therapy, linking the model-development work with drug development.
Use of funds
Expand operations and development efforts across AI-designed therapeutics.
Funding history
Series C · This round$140M